21 CFR Part 212 - CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
- SUBPART A — General Provisions (§§ 212.1 - 212.5)
- SUBPART B — Personnel and Resources (§§ 212.10 - 212.10)
- SUBPART C — Quality Assurance (§§ 212.20 - 212.20)
- SUBPART D — Facilities and Equipment (§§ 212.30 - 212.30)
- SUBPART E — Control of Components, Containers, and Closures (§§ 212.40 - 212.40)
- SUBPART F — Production and Process Controls (§§ 212.50 - 212.50)
- SUBPART G — Laboratory Controls (§§ 212.60 - 212.61)
- SUBPART H — Finished Drug Product Controls and Acceptance (§§ 212.70 - 212.71)
- SUBPART I — Packaging and Labeling (§§ 212.80 - 212.80)
- SUBPART J — Distribution (§§ 212.90 - 212.90)
- SUBPART K — Complaint Handling (§§ 212.100 - 212.100)
- SUBPART L — Records (§§ 212.110 - 212.110)
Source:
74 FR 65431, Dec. 10, 2009, unless otherwise noted.
Title 21 published on 2015-04-01.
No entries appear in the Federal Register after this date, for 21 CFR Part 212.